Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.
about
Modelling hepatitis C therapy--predicting effects of treatmentInfluence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome.A new model to produce infectious hepatitis C virus without the replication requirement.Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomesUnderstanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingSeverity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapyA perspective on modelling hepatitis C virus infection.Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)Understanding silibinin's modes of action against HCV using viral kinetic modelingMathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C InfectionPharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients.A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents.
P2860
Q26864673-12891F69-F985-40A2-9BBA-76495E3E2B8EQ30655795-0FE011ED-DACA-4DF1-A211-D0E0AF4BB41CQ33886707-3EF10BE3-3D54-429D-A870-64C5CD8BFB7EQ34208650-4046C960-4D89-4026-A68F-E3D7D37694D3Q34577514-44B3ACD2-D25C-41F5-B048-6B6D0A53CD33Q34675037-1AB8E250-D2D0-4125-B92B-DE35F4BB4586Q34759489-4664BE94-65AE-444A-8D61-ACA6C9B65CD2Q35610571-7496B7FD-7642-4C31-8665-DBB79616E160Q35878898-89690636-54DA-416D-B5FA-50D4A7C39AA3Q35894929-E6343B1C-9E19-4345-81FD-C3E6F427CE78Q36810400-8B34039D-BAB4-44FB-A707-2DF6EEC7A21AQ41435455-F116470F-E12A-4C9F-BD68-508E44F67F3CQ42705363-79D44DBB-FB60-4A87-AD17-30D6542A1C4EQ52579185-0BD3F191-A2C9-4B7E-8D68-49B2FDED43D2
P2860
Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@ast
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@en
type
label
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@ast
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@en
prefLabel
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@ast
Modelling hepatitis C virus ki ...... he final slope of viral decay.
@en
P2093
P2860
P1433
P1476
Modelling hepatitis C virus ki ...... the final slope of viral decay
@en
P2093
Harel Dahari
Scott J Cotler
Thomas J Layden
P2860
P304
P577
2009-01-01T00:00:00Z